Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06769308

Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients

Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients Undergoing Mechanical Ventilation: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
174 (estimated)
Sponsor
Università degli Studi di Ferrara · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs. The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a device already widely used in monitoring the anesthetic plan in the operating room. This tool would allow, through the processing of an EEG trace, the assessment of the level of sedation (qCON) and the probable algic response (qNOX), thus providing valuable information for the fine-tuning of the analgo-sedative plan.

Conditions

Interventions

TypeNameDescription
DEVICESedation titration according to qEEGSedation will be titrated according to the EEG derived indexes (qCON/qNOX)
PROCEDURESedation titration according to standard of careSedation will be provided according to the standard of care of the unit (clinical scales)

Timeline

Start date
2024-01-01
Primary completion
2026-12-31
Completion
2027-07-31
First posted
2025-01-10
Last updated
2025-01-10

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06769308. Inclusion in this directory is not an endorsement.